Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class I drug recalls - the high-risk category

Class I is the FDA's most serious recall category: a reasonable probability that using the product will cause serious health consequences or death. It is a small share of all recalls, but the one to check first if a medication you take appears here.

1,750 recalls, newest first.

Class I · High risk

PrimeZEN Black 6000 capsule

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Volt Candy Wholesale Club D-0453-2023
Class I · High risk

Artificial Tears

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Ongoing Sterility / contamination Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0919-2023
Class I · High risk

Easy Care First Aid 10 Person 2009 ANSI

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0253-2023
Class I · High risk

CVS First Aid Home

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0252-2023
Class I · High risk

Easy Care First Aid 25 Person 2009 ANSI

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0251-2023
Class I · High risk

Easy Care First Aid 10 Person 2009 ANSI

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0249-2023
Class I · High risk

Easy Care First Aid 25 Person 2009 ANSI

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0248-2023
Class I · High risk

Adventure First Aid 1.5

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0247-2023
Class I · High risk

Adventure First Aid 1.0

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0246-2023
Class I · High risk

Adventure Marine 150

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0245-2023
Class I · High risk

Easy Care first aid Burn Cream

Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.

Terminated Microbial contamination GFA Production Xiamen Co. Ltd. D-0244-2023
Class I · High risk

Epinephrine

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Terminated Failed specification Spectrum Laboratory Products, Inc. D-0180-2023
Class I · High risk

Epinephrine

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Terminated Failed specification Spectrum Laboratory Products, Inc. D-0179-2023
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0183-2023
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0182-2023
Class I · High risk

Advil (ibuprofen)

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0181-2023
Class I · High risk

Iohexol (300 mg Iodine/mL)

Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL

Terminated Labeling / mix-up BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy D-0086-2023
Class I · High risk

8.4% Sodium Bicarbonate Injection

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Terminated Packaging defect Exela Pharma Sciences LLC NDC 72572-740-20 D-0080-2023
Class I · High risk

8.4% Sodium Bicarbonate Injection

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

Terminated Packaging defect Exela Pharma Sciences LLC NDC 51754-5001-5 D-0079-2023

Recalls by year